Biomarcadores y Medicina Personalizada en Ciencias de la Salud
Universitat de Barcelona
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Universitat de Barcelona (2)
2024
-
Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases
Journal of Medicinal Chemistry, Vol. 67, Núm. 18, pp. 16533-16555
2018
-
Cbt modulates Foxo activation by positively regulating insulin signaling in Drosophila embryos
Biochimica et Biophysica Acta - Gene Regulatory Mechanisms, Vol. 1861, Núm. 9, pp. 878-891